WA
GWPH

WFG Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

WFG Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$14K Buy
135
+50
+59% +$5.38K ﹤0.01% 1051
2017
Q1 		$10K Buy
+85
New +$10.4K ﹤0.01% 1092
2016
Q3 		– Sell
-139
Closed -$13K – 1728
2016
Q2 		$13K Buy
139
+25
+22% +$2.1K ﹤0.01% 1029
2016
Q1 		$8K Hold
114
– – ﹤0.01% 1111
2015
Q4 		$8K Sell
114
-65
-36% -$5.29K ﹤0.01% 1146
2015
Q3 		$16K Buy
179
+65
+57% +$7.23K 0.01% 970
2015
Q2 		$14K Buy
114
+64
+128% +$7.26K ﹤0.01% 1096
2015
Q1 		$5K Hold
50
– – ﹤0.01% 1386
2014
Q4 		$3K Hold
50
– – ﹤0.01% 1803
2014
Q3 		$4K Hold
50
– – ﹤0.01% 1742
2014
Q2 		$5K Hold
50
– – ﹤0.01% 1669
2014
Q1 		$3K Buy
+50
New +$2.97K ﹤0.01% 1770

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

WFG Advisors's GWPH Position: Q2 2017 in Review

WFG Advisors increased its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 59% in Q2 2017, buying an estimated $5.38K and bringing the position to 135 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

WFG Advisors first reported a position in GWPH in Q1 2014 and has held it in 12 quarters since. The position peaked at $16K in Q3 2015. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

  • WFG Advisors held 135 shares of GW Pharmaceuticals Plc American Depositary Shares worth $14K as of Q2 2017.
  • WFG Advisors bought 50 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $5.38K.
  • GW Pharmaceuticals Plc American Depositary Shares made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1051 holding.
  • WFG Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and has held it in 12 quarters since.
  • WFG Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $16K in Q3 2015.
  • 170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.